Epilepsy is one of those diseases there’s no coming back from. Once diagnosed, the best you can do is find suitable ways to cope with it. It’s even more challenging if your little one is afflicted, and it can have a tremendous impact on the families affected. While there is currently no cure for epilepsy, there’s a host of anti-seizure meds that can reduce the frequency of the seizures and give the child a healthier life.
CBD has recently joined the ranks of effective anti-seizure meds. A study held in Australia and New Zealand found that CBD gel is effective against seizures, especially in children who have severe epilepsy. The study was led by professors Lynette Sadlier, a pediatric neurologist at the University of Otago, Wellington, and Ingrid Scheffer, a pediatric neurologist at the University of Melbourne. In total, 48 patients between the age of 3 and 16 years enrolled in…
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]